{"id":75866,"date":"2022-08-12T11:21:00","date_gmt":"2022-08-12T04:21:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2022081211210075866"},"modified":"2022-08-12T22:15:32","modified_gmt":"2022-08-12T14:15:32","slug":"%e8%af%ba%e8%af%9a%e5%81%a5%e5%8d%8e%e5%a5%a5%e5%b8%83%e6%9b%bf%e5%b0%bc%e6%b2%bb%e7%96%97%e5%a4%8d%e5%8f%91-%e9%9a%be%e6%b2%bb%e6%80%a7%e8%be%b9%e7%bc%98%e5%8c%ba%e6%b7%8b%e5%b7%b4%e7%98%a4%e7%9a%84","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2022081211210075866","title":{"rendered":"\u8bfa\u8bda\u5065\u534e\u5965\u5e03\u66ff\u5c3c\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624\u7684\u65b0\u9002\u5e94\u75c7\u4e0a\u5e02\u7533\u8bf7\u5728\u4e2d\u56fd\u83b7\u53d7\u7406"},"content":{"rendered":"

\u5317\u4eac<\/span>2022\u5e748\u670812\u65e5<\/span> \/\u7f8e\u901a\u793e\/ — \u751f\u7269\u533b\u836f\u9ad8\u79d1\u6280\u516c\u53f8\u8bfa\u8bda\u5065\u534e\uff08\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a09969\uff09\u4eca\u5929\u5ba3\u5e03\uff0c\u4e2d\u56fd\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u836f\u54c1\u5ba1\u8bc4\u4e2d\u5fc3\uff08CDE\uff09\u5df2\u53d7\u7406\u5e03\u9c81\u987f\u916a\u6c28\u9178\u6fc0\u9176\uff08BTK\uff09\u6291\u5236\u5242\u5965\u5e03\u66ff\u5c3c\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624\uff08MZL\uff09\u60a3\u8005\u7684\u65b0\u9002\u5e94\u75c7\u4e0a\u5e02\u7533\u8bf7\uff08sNDA\uff09\u3002<\/p>\n

\u5317\u4eac\u5927\u5b66\u80bf\u7624\u533b\u9662\u5927\u5185\u79d1\u4e3b\u4efb\u3001\u6dcb\u5df4\u7624\u79d1\u4e3b\u4efb\u6731\u519b\u6559\u6388\u8bf4\uff1a"\u4f5c\u4e3a\u4e3b\u8981\u7814\u7a76\u8005\uff0c\u5f88\u9ad8\u5174\u770b\u5230\u5965\u5e03\u66ff\u5c3c\u5728\u6bcf\u5929\u4e00\u6b21150 \u6beb\u514b\u5242\u91cf\u4e0b\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u60a3\u8005\u8fbe\u5230\u4e86\u9884\u8bbe\u7684\u4e3b\u8981\u7814\u7a76\u7ec8\u70b9\uff0c\u663e\u793a\u6301\u7eed\u7684\u7597\u6548\u53ca\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u3002\u76ee\u524d\uff0c\u56fd\u5185\u5c1a\u65e0BTK\u6291\u5236\u5242\u83b7\u6279\u7528\u4e8e\u590d\u53d1\/\u96be\u6cbb\u7684MZL\u60a3\u8005\uff0c\u671f\u5f85\u5965\u5e03\u66ff\u5c3c\u53ef\u4ee5\u586b\u8865\u8fd9\u4e00\u9886\u57df\u7684\u7a7a\u767d\u3002"<\/p>\n

\u8bfa\u8bda\u5065\u534e\u8054\u5408\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5d14\u9701\u677e\u535a\u58eb\u8bf4\uff1a"MZL\u662f\u5e38\u89c1\u7684\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u7c7b\u578b\uff0c\u5728\u6240\u6709NHL\u4e2d\u5360\u6bd4\u7ea67~10%[1]<\/span><\/sup>\uff0c\u5728\u8001\u5e74\u4eba\u4e2d\uff0c\u5c24\u5176\u662f80\u5c81\u4ee5\u4e0a\u7684\u8001\u5e74\u4eba\u4e2d\uff0c\u53d1\u75c5\u7387\u8f83\u9ad8\u3002\u4f46\u76ee\u524d\u5bf9\u4e8e\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u7684\u6cbb\u7597\u624b\u6bb5\u6709\u9650\uff0c\u5965\u5e03\u66ff\u5c3c\u6709\u671b\u6210\u4e3a\u56fd\u5185\u9996\u4e2a\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u7684BTK\u6291\u5236\u5242\u3002\u6211\u4eec\u5e0c\u671b\u5965\u5e03\u66ff\u5c3c\u65e9\u65e5\u60e0\u53ca\u4e9f\u9700\u521b\u65b0\u6cbb\u7597\u7684MZL\u60a3\u8005\u3002"<\/p>\n

\u5965\u5e03\u66ff\u5c3c\u4e8e2020\u5e7412\u670825\u65e5\u5728\u4e2d\u56fd\u83b7\u6279\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5(CLL)\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624(SLL)\u3001\u4ee5\u53ca\u590d\u53d1\/\u96be\u6cbb\u6027\u5957\u7ec6\u80de\u6dcb\u5df4\u7624(MCL) \u4e24\u9879\u9002\u5e94\u75c7\uff0c\u5e76\u4e8e2021\u5e74\u5e95\u7eb3\u5165\u56fd\u5bb6\u533b\u4fdd\u3002\u4eca\u5e743\u6708\uff0c\u5965\u5e03\u66ff\u5c3c\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u534e\u6c0f\u5de8\u7403\u86cb\u767d\u8840\u75c7\uff08WM\uff09\u7684\u65b0\u9002\u5e94\u75c7\u4e0a\u5e02\u7533\u8bf7\u5728\u4e2d\u56fd\u83b7\u53d7\u7406\u3002<\/p>\n

\u5173\u4e8e\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624\uff08<\/b>MZL<\/b>\uff09<\/b><\/p>\n

\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624\uff08MZL\uff09\u662f\u4e00\u79cd\u5e38\u89c1\u7684B\u7ec6\u80de\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08B-NHL\uff09\uff0c\u53d1\u75c5\u7387\u4ec5\u6b21\u4e8e\u5f25\u6f2b\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\uff08DLBCL\uff09\u548c\u6ee4\u6ce1\u6027\u6dcb\u5df4\u7624\uff08FL\uff09\uff0c\u7ea6\u5360\u6240\u6709 NHL \u7684 7~10%\u3002\u6309\u7167WHO\u5206\u7c7b\uff0cMZL\u53ef\u5206\u4e3a\u4e09\u4e2a\u4e9a\u578b\uff1a\u9ecf\u819c\u76f8\u5173\u6dcb\u5df4\u7ec4\u7ec7\uff08MALT\uff09\u6dcb\u5df4\u7624\u3001\u6dcb\u5df4\u7ed3\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624\uff08NMZL\uff09\u548c\u813e\u810f\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624\uff08SMZL\uff09\u3002\u867d\u7136MZL\u5c5e\u4e8e\u60f0\u6027\u6dcb\u5df4\u7624\uff0c\u4f46\u662f\u5728\u73b0\u6709\u7684\u6cbb\u7597\u624b\u6bb5\u4e0b\uff0c\u4ecd\u662f\u4e0d\u53ef\u6cbb\u6108\u7684\u6076\u6027\u80bf\u7624 \uff0c\u5c24\u5176\u662f\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u60a3\u8005\u7684\u9884\u540e\u66f4\u5dee\u3002\u76ee\u524d\u4e34\u5e8a\u4e0a\u5c1a\u65e0\u516c\u8ba4\u7684\u6807\u51c6\u6cbb\u7597\u65b9\u6cd5\uff0c\u7528\u4e8e\u590d\u53d1\/\u96be\u6cbb\u60a3\u8005\u7684\u633d\u6551\u6cbb\u7597\u9009\u62e9\u6709\u9650\u3002\u8fc4\u4eca\u4e3a\u6b62\uff0c\u6211\u56fd\u4e5f\u5c1a\u65e0\u6709\u6548\u7684\u9776\u5411\u836f\u7269\u83b7\u6279\u7528\u4e8e\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u3002\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u5b58\u5728\u672a\u88ab\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u3002<\/p>\n

\u5173\u4e8e\u5965\u5e03\u66ff\u5c3c<\/b><\/p>\n

\u5965\u5e03\u66ff\u5c3c\u662f\u8bfa\u8bda\u5065\u534e\u7814\u53d1\u76841\u7c7b\u65b0\u836f\uff0c\u662f\u5177\u9ad8\u5ea6\u9009\u62e9\u6027\u7684\u65b0\u578bBTK\u6291\u5236\u5242\uff0c\u65e8\u5728\u7528\u4e8e\u6cbb\u7597\u6dcb\u5df4\u7624\u53ca\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u3002<\/p>\n

\u5965\u5e03\u66ff\u5c3c\u4e8e2020\u5e7412\u670825\u65e5\u5728\u4e2d\u56fd\u9644\u6761\u4ef6\u83b7\u6279\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5(CLL)\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624(SLL)\u3001\u4ee5\u53ca\u590d\u53d1\/\u96be\u6cbb\u6027\u5957\u7ec6\u80de\u6dcb\u5df4\u7624(MCL) \u4e24\u9879\u9002\u5e94\u75c7\u30022021\u5e74\u5e95\uff0c\u5965\u5e03\u66ff\u5c3c\u88ab\u7eb3\u5165\u56fd\u5bb6\u533b\u4fdd\u4ee5\u60e0\u53ca\u66f4\u591a\u6dcb\u5df4\u7624\u60a3\u8005\u3002<\/p>\n

\u9664\u6b64\u4e4b\u5916\uff0c\u6b63\u5728\u4e2d\u56fd\u548c\u7f8e\u56fd\u5f00\u5c55\u4ee5\u5965\u5e03\u66ff\u5c3c\u4f5c\u4e3a\u5355\u72ec\u7528\u836f\u6216\u8054\u5408\u7528\u836f\u7684\u591a\u4e2d\u5fc3\u3001\u591a\u9002\u5e94\u75c7\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n

\u5965\u5e03\u66ff\u5c3c\u8fd8\u5728\u4e2d\u56fd\u5f00\u5c55\u6cbb\u7597\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624(MZL)\u3001\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u6dcb\u5df4\u7624(CNSL)\u3001\u534e\u6c0f\u5de8\u7403\u86cb\u767d\u8840\u75c7(WM)\u53ca\u5f25\u6f2b\u6027\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624(DLBCL)\u5728\u5185\u7684\u591a\u79cdB\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n

\u5965\u5e03\u66ff\u5c3c\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6388\u4e88\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a\uff08Breakthrough Therapy Designation\uff09\uff0c\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\uff08R\/R MCL\uff09\u3002<\/p>\n

\u5965\u5e03\u66ff\u5c3c\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\uff08MS\uff09\u7684\u5168\u7403II\u671f\u4e34\u5e8a\u7814\u7a76\uff0c\u4ee5\u53ca\u5728\u4e2d\u56fd\u5f00\u5c55\u6cbb\u7597\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\uff08SLE\uff09\u3001\u539f\u53d1\u514d\u75ab\u6027\u8840\u5c0f\u677f\u51cf\u5c11\u75c7\uff08ITP\uff09\u548c\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5\uff08NMOSD\uff09\u7684\u4e34\u5e8a\u8bd5\u9a8c\u6b63\u5728\u5bf9\u5965\u5e03\u66ff\u5c3c\u8fdb\u884c\u8bc4\u4f30\u3002<\/p>\n

\u5173\u4e8e\u8bfa\u8bda\u5065\u534e<\/b><\/p>\n

\u8bfa\u8bda\u5065\u534e\uff08\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a09969\uff09\u662f\u4e00\u5bb6\u5546\u4e1a\u5316\u9636\u6bb5\u7684\u751f\u7269\u533b\u836f\u9ad8\u79d1\u6280\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u6076\u6027\u80bf\u7624\u53ca\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u6cbb\u7597\u9886\u57df\u7684\u4e00\u7c7b\u65b0\u836f\u7814\u5236\uff0c\u9002\u7528\u4e8e\u6cbb\u7597\u6dcb\u5df4\u7624\u3001\u5b9e\u4f53\u7624\u548c\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u3002\u73b0\u6709\u591a\u4e2a\u65b0\u836f\u4ea7\u54c1\u5904\u4e8e\u5546\u4e1a\u5316\u3001\u4e34\u5e8a\u53ca\u4e34\u5e8a\u524d\u7814\u53d1\u9636\u6bb5\u3002\u516c\u53f8\u5728\u5317\u4eac\u3001\u5357\u4eac\u3001\u4e0a\u6d77\u3001\u5e7f\u5dde\u3001\u9999\u6e2f\u4ee5\u53ca\u7f8e\u56fd\u8bbe\u6709\u5206\u652f\u673a\u6784\u3002<\/p>\n

[1] Cerhan JR, Habermann TM. Epidemiology of Marginal Zone Lymphoma. Ann Lymphoma. 2021 Mar;5:1. doi: 10.21037\/aol-20-28. Epub 2021 Mar 30. PMID: 33829216; PMCID: PMC8020862.
<\/sup>Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Epidemiology of Non-Hodgkin’s Lymphoma. Med Sci (Basel)<\/span>. 2021 Jan 30;9(1):5. doi: 10.3390\/medsci9010005. PMID: 33573146; PMCID: PMC7930980.<\/sup><\/span><\/p>\n

\u76f8\u5173\u94fe\u63a5\uff1ahttps:\/\/cn.innocarepharma.com\/cn\/<\/a><\/span><\/p>\n

 <\/p>\n

\n\n\n\n\n\n\n\n
\n

\u8054\u7cfb\u4eba<\/b><\/span><\/p>\n<\/td>\n

<\/td>\n<\/tr>\n
\n

\u5a92\u4f53<\/b><\/span><\/p>\n<\/td>\n

\n

\u6295\u8d44\u8005<\/b><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

\u9646\u6625\u534e<\/span><\/p>\n<\/td>\n

<\/td>\n<\/tr>\n
\n

86-10-66609879 <\/span><\/p>\n<\/td>\n

\n

86-10-66609999<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

chunhua.lu@innocarepharma.com<\/a>  <\/span><\/p>\n<\/td>\n

\n

ir@innocarepharma.com<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

\u5317\u4eac2022\u5e748\u670812\u65e5 \/\u7f8e\u901a\u793e\/ — \u751f\u7269\u533b\u836f\u9ad8\u79d1\u6280\u516c\u53f8\u8bfa\u8bda\u5065\u534e\uff08\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a09969\uff09\u4eca\u5929\u5ba3\u5e03\uff0c\u4e2d\u56fd\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u836f\u54c1\u5ba1\u8bc4\u4e2d\u5fc3\uff08CDE\uff09\u5df2\u53d7\u7406\u5e03\u9c81\u987f\u916a\u6c28\u9178\u6fc0\u9176\uff08BTK\uff09\u6291\u5236\u5242\u5965\u5e03\u66ff\u5c3c\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624\uff08MZL\uff09\u60a3\u8005\u7684\u65b0\u9002\u5e94\u75c7\u4e0a\u5e02\u7533\u8bf7\uff08sNDA\uff09\u3002 \u5317\u4eac\u5927\u5b66\u80bf\u7624\u533b\u9662\u5927\u5185\u79d1\u4e3b\u4efb\u3001\u6dcb\u5df4\u7624\u79d1\u4e3b\u4efb\u6731\u519b\u6559\u6388\u8bf4\uff1a"\u4f5c\u4e3a\u4e3b\u8981\u7814\u7a76\u8005\uff0c\u5f88\u9ad8\u5174\u770b\u5230\u5965\u5e03\u66ff\u5c3c\u5728\u6bcf\u5929\u4e00\u6b21150 \u6beb\u514b\u5242\u91cf\u4e0b\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u60a3\u8005\u8fbe\u5230\u4e86\u9884\u8bbe\u7684\u4e3b\u8981\u7814\u7a76\u7ec8\u70b9\uff0c\u663e\u793a\u6301\u7eed\u7684\u7597\u6548\u53ca\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u3002\u76ee\u524d\uff0c\u56fd\u5185\u5c1a\u65e0BTK\u6291\u5236\u5242\u83b7\u6279\u7528\u4e8e\u590d\u53d1\/\u96be\u6cbb\u7684MZL\u60a3\u8005\uff0c\u671f\u5f85\u5965\u5e03\u66ff\u5c3c\u53ef\u4ee5\u586b\u8865\u8fd9\u4e00\u9886\u57df\u7684\u7a7a\u767d\u3002" \u8bfa\u8bda\u5065\u534e\u8054\u5408\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5d14\u9701\u677e\u535a\u58eb\u8bf4\uff1a"MZL\u662f\u5e38\u89c1\u7684\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u7c7b\u578b\uff0c\u5728\u6240\u6709NHL\u4e2d\u5360\u6bd4\u7ea67~10%[1]\uff0c\u5728\u8001\u5e74\u4eba\u4e2d\uff0c\u5c24\u5176\u662f80\u5c81\u4ee5\u4e0a\u7684\u8001\u5e74\u4eba\u4e2d\uff0c\u53d1\u75c5\u7387\u8f83\u9ad8\u3002\u4f46\u76ee\u524d\u5bf9\u4e8e\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u7684\u6cbb\u7597\u624b\u6bb5\u6709\u9650\uff0c\u5965\u5e03\u66ff\u5c3c\u6709\u671b\u6210\u4e3a\u56fd\u5185\u9996\u4e2a\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u7684BTK\u6291\u5236\u5242\u3002\u6211\u4eec\u5e0c\u671b\u5965\u5e03\u66ff\u5c3c\u65e9\u65e5\u60e0\u53ca\u4e9f\u9700\u521b\u65b0\u6cbb\u7597\u7684MZL\u60a3\u8005\u3002" \u5965\u5e03\u66ff\u5c3c\u4e8e2020\u5e7412\u670825\u65e5\u5728\u4e2d\u56fd\u83b7\u6279\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5(CLL)\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624(SLL)\u3001\u4ee5\u53ca\u590d\u53d1\/\u96be\u6cbb\u6027\u5957\u7ec6\u80de\u6dcb\u5df4\u7624(MCL) \u4e24\u9879\u9002\u5e94\u75c7\uff0c\u5e76\u4e8e2021\u5e74\u5e95\u7eb3\u5165\u56fd\u5bb6\u533b\u4fdd\u3002\u4eca\u5e743\u6708\uff0c\u5965\u5e03\u66ff\u5c3c\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u534e\u6c0f\u5de8\u7403\u86cb\u767d\u8840\u75c7\uff08WM\uff09\u7684\u65b0\u9002\u5e94\u75c7\u4e0a\u5e02\u7533\u8bf7\u5728\u4e2d\u56fd\u83b7\u53d7\u7406\u3002 \u5173\u4e8e\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624\uff08MZL\uff09 \u8fb9\u7f18\u533a\u6dcb\u5df4\u7624\uff08MZL\uff09\u662f\u4e00\u79cd\u5e38\u89c1\u7684B\u7ec6\u80de\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08B-NHL\uff09\uff0c\u53d1\u75c5\u7387\u4ec5\u6b21\u4e8e\u5f25\u6f2b\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\uff08DLBCL\uff09\u548c\u6ee4\u6ce1\u6027\u6dcb\u5df4\u7624\uff08FL\uff09\uff0c\u7ea6\u5360\u6240\u6709 NHL \u7684 7~10%\u3002\u6309\u7167WHO\u5206\u7c7b\uff0cMZL\u53ef\u5206\u4e3a\u4e09\u4e2a\u4e9a\u578b\uff1a\u9ecf\u819c\u76f8\u5173\u6dcb\u5df4\u7ec4\u7ec7\uff08MALT\uff09\u6dcb\u5df4\u7624\u3001\u6dcb\u5df4\u7ed3\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624\uff08NMZL\uff09\u548c\u813e\u810f\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624\uff08SMZL\uff09\u3002\u867d\u7136MZL\u5c5e\u4e8e\u60f0\u6027\u6dcb\u5df4\u7624\uff0c\u4f46\u662f\u5728\u73b0\u6709\u7684\u6cbb\u7597\u624b\u6bb5\u4e0b\uff0c\u4ecd\u662f\u4e0d\u53ef\u6cbb\u6108\u7684\u6076\u6027\u80bf\u7624 \uff0c\u5c24\u5176\u662f\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u60a3\u8005\u7684\u9884\u540e\u66f4\u5dee\u3002\u76ee\u524d\u4e34\u5e8a\u4e0a\u5c1a\u65e0\u516c\u8ba4\u7684\u6807\u51c6\u6cbb\u7597\u65b9\u6cd5\uff0c\u7528\u4e8e\u590d\u53d1\/\u96be\u6cbb\u60a3\u8005\u7684\u633d\u6551\u6cbb\u7597\u9009\u62e9\u6709\u9650\u3002\u8fc4\u4eca\u4e3a\u6b62\uff0c\u6211\u56fd\u4e5f\u5c1a\u65e0\u6709\u6548\u7684\u9776\u5411\u836f\u7269\u83b7\u6279\u7528\u4e8e\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u3002\u590d\u53d1\/\u96be\u6cbb\u6027MZL\u5b58\u5728\u672a\u88ab\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u3002 \u5173\u4e8e\u5965\u5e03\u66ff\u5c3c \u5965\u5e03\u66ff\u5c3c\u662f\u8bfa\u8bda\u5065\u534e\u7814\u53d1\u76841\u7c7b\u65b0\u836f\uff0c\u662f\u5177\u9ad8\u5ea6\u9009\u62e9\u6027\u7684\u65b0\u578bBTK\u6291\u5236\u5242\uff0c\u65e8\u5728\u7528\u4e8e\u6cbb\u7597\u6dcb\u5df4\u7624\u53ca\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u3002 \u5965\u5e03\u66ff\u5c3c\u4e8e2020\u5e7412\u670825\u65e5\u5728\u4e2d\u56fd\u9644\u6761\u4ef6\u83b7\u6279\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5(CLL)\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624(SLL)\u3001\u4ee5\u53ca\u590d\u53d1\/\u96be\u6cbb\u6027\u5957\u7ec6\u80de\u6dcb\u5df4\u7624(MCL) \u4e24\u9879\u9002\u5e94\u75c7\u30022021\u5e74\u5e95\uff0c\u5965\u5e03\u66ff\u5c3c\u88ab\u7eb3\u5165\u56fd\u5bb6\u533b\u4fdd\u4ee5\u60e0\u53ca\u66f4\u591a\u6dcb\u5df4\u7624\u60a3\u8005\u3002 \u9664\u6b64\u4e4b\u5916\uff0c\u6b63\u5728\u4e2d\u56fd\u548c\u7f8e\u56fd\u5f00\u5c55\u4ee5\u5965\u5e03\u66ff\u5c3c\u4f5c\u4e3a\u5355\u72ec\u7528\u836f\u6216\u8054\u5408\u7528\u836f\u7684\u591a\u4e2d\u5fc3\u3001\u591a\u9002\u5e94\u75c7\u4e34\u5e8a\u8bd5\u9a8c\u3002 \u5965\u5e03\u66ff\u5c3c\u8fd8\u5728\u4e2d\u56fd\u5f00\u5c55\u6cbb\u7597\u8fb9\u7f18\u533a\u6dcb\u5df4\u7624(MZL)\u3001\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u6dcb\u5df4\u7624(CNSL)\u3001\u534e\u6c0f\u5de8\u7403\u86cb\u767d\u8840\u75c7(WM)\u53ca\u5f25\u6f2b\u6027\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624(DLBCL)\u5728\u5185\u7684\u591a\u79cdB\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002 \u5965\u5e03\u66ff\u5c3c\u83b7\u5f97\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6388\u4e88\u7a81\u7834\u6027\u7597\u6cd5\u8ba4\u5b9a\uff08Breakthrough Therapy Designation\uff09\uff0c\u7528\u4e8e\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u6027\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\uff08R\/R MCL\uff09\u3002 \u5965\u5e03\u66ff\u5c3c\u6cbb\u7597\u591a\u53d1\u6027\u786c\u5316\uff08MS\uff09\u7684\u5168\u7403II\u671f\u4e34\u5e8a\u7814\u7a76\uff0c\u4ee5\u53ca\u5728\u4e2d\u56fd\u5f00\u5c55\u6cbb\u7597\u7cfb\u7edf\u6027\u7ea2\u6591\u72fc\u75ae\uff08SLE\uff09\u3001\u539f\u53d1\u514d\u75ab\u6027\u8840\u5c0f\u677f\u51cf\u5c11\u75c7\uff08ITP\uff09\u548c\u89c6\u795e\u7ecf\u810a\u9ad3\u708e\u8c31\u7cfb\u75be\u75c5\uff08NMOSD\uff09\u7684\u4e34\u5e8a\u8bd5\u9a8c\u6b63\u5728\u5bf9\u5965\u5e03\u66ff\u5c3c\u8fdb\u884c\u8bc4\u4f30\u3002 \u5173\u4e8e\u8bfa\u8bda\u5065\u534e \u8bfa\u8bda\u5065\u534e\uff08\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a09969\uff09\u662f\u4e00\u5bb6\u5546\u4e1a\u5316\u9636\u6bb5\u7684\u751f\u7269\u533b\u836f\u9ad8\u79d1\u6280\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u6076\u6027\u80bf\u7624\u53ca\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u6cbb\u7597\u9886\u57df\u7684\u4e00\u7c7b\u65b0\u836f\u7814\u5236\uff0c\u9002\u7528\u4e8e\u6cbb\u7597\u6dcb\u5df4\u7624\u3001\u5b9e\u4f53\u7624\u548c\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u3002\u73b0\u6709\u591a\u4e2a\u65b0\u836f\u4ea7\u54c1\u5904\u4e8e\u5546\u4e1a\u5316\u3001\u4e34\u5e8a\u53ca\u4e34\u5e8a\u524d\u7814\u53d1\u9636\u6bb5\u3002\u516c\u53f8\u5728\u5317\u4eac\u3001\u5357\u4eac\u3001\u4e0a\u6d77\u3001\u5e7f\u5dde\u3001\u9999\u6e2f\u4ee5\u53ca\u7f8e\u56fd\u8bbe\u6709\u5206\u652f\u673a\u6784\u3002 [1] Cerhan JR, Habermann TM. Epidemiology of Marginal Zone Lymphoma. Ann Lymphoma. 2021 Mar;5:1. doi: 10.21037\/aol-20-28. Epub 2021 Mar 30. PMID: 33829216; PMCID: PMC8020862.Thandra KC, Barsouk A, Saginala K, Padala SA,… Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":8278,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-75866","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/75866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=75866"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/75866\/revisions"}],"predecessor-version":[{"id":75867,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/75866\/revisions\/75867"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/8278"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=75866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=75866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=75866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}